Highly sensitive Covid vaccine could be a test of resilience for the EU-FMD anti-counterfeiting elements
December 21, 2020
September 22, 2021

Download now avaliable: Jazz Pharmaceuticals Health Check and Brand Risk Assessment Case Study

Putting patient safety first | How the Excellis Health Check and Brand Risk Assessment programme is helping pharma firms minimise security challenges

In an age where the protection, security and traceability of medicines is constantly under the spotlight, pharma companies of all sizes must rise to the challenge of developing watertight systems and processes across their entire operation.

This case study explores how a comprehensive risk assessment service from Excellis Health Solutions has enabled Jazz Pharmaceuticals’ supply chain teams to assess their traceability compliance readiness, strengthen their brand protection programme and identify opportunities to exemplify industry best practice.

With patient safety a critical concern, complying with global track and trace mandates and managing and mitigating risk is an essential component of safe and effective pharmaceutical supply management.

This study explains how the Excellis health check and brand risk assessment can help pharma firms minimise security challenges, and is available to download from our knowledge base.

Download today:

DOWNLOAD – Jazz Pharmaceuticals Risk Assessment Case Study

Excellis Europe has successfully supported, from strategy to sustainability, a range of biotech/startups in US and Europe. We can help contact getsecured@excellishealth.eu and acheive success.

Show all

Leave a Reply

Your email address will not be published. Required fields are marked *